Clinical Trial: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07662044) titled 'A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus' on June 18.

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron alone or in combination with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated with other background glucose-lowering medication.

Study Start Date: July 06

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus

Intervention: DR...